The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Emergency Department Visits for Antibiotic‐Associated Adverse Events
Abstract
BACKGROUND: Drug-related adverse events are an under-appreciated consequence of antibiotic use, and the national magnitude and scope of these events have not been studied. Our objective was to estimate and compare the numbers and rates of emergency department (ED) visits for drug-related adverse events associated with systemic antibiotics in the United States by drug class, individual drug, and event type. METHODS: We analyzed drug-related adverse events from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (2004-2006) and outpatient prescriptions from national sample surveys of ambulatory care practices, the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey (2004-2005). RESULTS: On the basis of 6614 cases, an estimated 142,505 visits (95% confidence interval [CI], 116,506-168,504 visits) annually were made to US EDs for drug-related adverse events attributable to systemic antibiotics. Antibiotics were implicated in 19.3% of all ED visits for drug-related adverse events. Most ED visits for antibiotic-associated adverse events were for allergic reactions (78.7% of visits; 95% CI, 75.3%-82.1% of visits). One-half of the estimated ED visits were attributable to penicillins (36.9% of visits; 95% CI, 34.7%-39.2% of visits) and cephalosporins (12.2%; 95% CI, 10.9%-13.5%). Among commonly prescribed antibiotics, sulfonamides and clindamycin were associated with the highest rate of ED visits (18.9 ED visits per 10,000 outpatient prescription visits [95% CI, 13.1-24.7 ED visits per 10,000 outpatient prescription visits] and 18.5 ED visits per 10,000 outpatient prescription visits [95% CI, 12.1-25.0 ED visits per 10,000 outpatient prescription visits], respectively). Compared with all other antibiotic classes, sulfonamides were associated with a significantly higher rate of moderate-to-severe allergic reactions (4.3% [95% CI, 2.9%-5.8%] vs. 1.9 % [95% CI, 1.5%-2.3%]), and sulfonamides and fluoroquinolones were associated with a significantly higher rate of neurologic or psychiatric disturbances (1.4% [95% CI, 1.0%-1.7%] vs. 0.5% [95% CI, 0.4%-0.6%]). CONCLUSIONS: Antibiotic-associated adverse events lead to many ED visits, and allergic reactions are the most common events. Minimizing unnecessary antibiotic use by even a small percentage could significantly reduce the immediate and direct risks of drug-related adverse events in individual patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events
Budnitz, D. S., Pollock, D. A., Weidenbach, K. N., Mendelsohn, A. B., Schroeder, T. J., & Annest, J. L. (2006) · JAMA · doi:10.1001/jama.296.15.1858 · Cited by 893
Self-citationButler, C. C., Rollnick, S., Pill, R., Maggs-Rapport, F., & Stott, N. (1998) · BMJ · doi:10.1136/bmj.317.7159.637 · Cited by 752
Antibiotic Prescribing for Children With Colds, Upper Respiratory Tract Infections, and Bronchitis
Nyquist, A.-C. (1998) · JAMA · doi:10.1001/jama.279.11.875 · Cited by 679
Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults
Budnitz, D. S., Shehab, N., Kegler, S. R., & Richards, C. L. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-11-200712040-00006 · Cited by 607
Self-citationWise, R., Hart, T., Cars, O., Streulens, M., Helmuth, R., Huovinen, P., & Sprenger, M. (1998) · BMJ · doi:10.1136/bmj.317.7159.609 · Cited by 592
Excessive antibiotic use for acute respiratory infections in the United States
Gonzales, R., Malone, D. C., Maselli, J. H., & Sande, M. A. (2001) · Clinical Infectious Diseases · doi:10.1086/322627 · Cited by 531
Prevention of infective endocarditis: Guidelines from the American Heart Association
Wilson, W., Taubert, K. A., Gewitz, M., Lockhart, P. B., Baddour, L. M., Levison, M., Bolger, A., Cabell, C. H., Takahashi, M., Baltimore, R. S., et al. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0346 · Cited by 484
Gould, F. K. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl121 · Cited by 398
U.S. Consumer product safety commission
Humphrey, N. (1990) · Journal of Pediatric Health Care · doi:10.1016/0891-5245(90)90077-j · Cited by 390
Outpatient gatifloxacin therapy and dysglycemia in older adults.
Park-Wyllie, L. Y., Juurlink, D. N., Kopp, A., Shah, B. R., Stukel, T. A., Stumpo, C., Dresser, L., Low, D. E., & Mamdani, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055191 · Cited by 367
Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study
Kumar, S., Little, P., & Britten, N. (2003) · BMJ · doi:10.1136/bmj.326.7381.138 · Cited by 315
A review of the role of antibiotic policies in the control of antibiotic resistance
Gould, I. M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.459 · Cited by 241
Serotonin Toxicity Associated with the Use of Linezolid: A Review of Postmarketing Data
Lawrence, K. R., Adra, M., & Gillman, P. K. (2006) · Clinical Infectious Diseases · doi:10.1086/503839 · Cited by 200
Antibiotic Treatment of Children With Sore Throat
Linder, J. A. (2005) · JAMA · doi:10.1001/jama.294.18.2315 · Cited by 197
Schwartz, B. (1997) · JAMA · doi:10.1001/jama.1997.03550110082041 · Cited by 171
Institute of Medicine (1998) · National Academies Press eBooks · doi:10.17226/6121 · Cited by 130
Adverse Drug Reactions Related to the Use of Fluoroquinolone Antimicrobials
Leone, R., Venegoni, M., Motola, D., Moretti, U., Piazzetta, V., Cocci, A., Resi, D., Mozzo, F., Velo, G., Burzilleri, L., et al. (2003) · Drug Safety · doi:10.2165/00002018-200326020-00004 · Cited by 127
Trends in antibiotic prescribing for adults in the United States—1995 to 2002
Roumie, C. L., Halasa, N., Grijalva, C. G., Edwards, K. M., Zhu, Y., Dittus, R. S., & Griffin, M. R. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0148.x · Cited by 124
Wood, F., Simpson, S. A., & Butler, C. (2007) · Family Practice · doi:10.1093/fampra/cmm040 · Cited by 118
Tensions in antibiotic prescribing
Metlay, J. P., Shea, J. A., Crossette, L. B., & Asch, D. A. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.10711.x · Cited by 115
Desire for antibiotics and antibiotic prescribing for adults with upper respiratory tract infections
Linder, J. A., & Singer, D. E. (2003) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2003.21101.x · Cited by 97
Gill, J. M., Fleischut, P. M., Haas, S., Pellini, B., Crawford, A. G., & Nash, D. B. (2006) · PubMed · Cited by 94
Jhung, M. A., Budnitz, D. S., Mendelsohn, A. B., Weidenbach, K. N., Nelson, T. D., & Pollock, D. A. (2007) · Medical Care · doi:10.1097/mlr.0b013e318041f737 · Cited by 83
Self-citationThe risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.
Glasheen, J. J., Fugit, R. V., & Prochazka, A. V. (2005) · Europe PMC (PubMed Central) · doi:10.1111/j.1525-1497.2005.0136.x · Cited by 80
Sachs, B., Riegel, S., Seebeck, J., Beier, R., Schichler, D., Barger, A., Merk, H. F., & Erdmann, S. (2006) · Drug Safety · doi:10.2165/00002018-200629110-00008 · Cited by 72
Antimicrobial Resistance: Issues and Options
Infections, F. O. E. (1998) · Cited by 71
Antibiotics for Common Respiratory Tract Infections in Adults
Hirschmann, J. V. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.256 · Cited by 64
Medication therapy in ambulatory medical care: United States, 2003-04.
Raofi, S., & Schappert, S. M. (2006) · PubMed · Cited by 53
Ma, J., Stafford, R. S., Cockburn, I., & Finkelstein, S. N. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80136-4 · Cited by 53
Gilberg, K., Laouri, M., Wade, S. W., & Isonaka, S. (2003) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2003.9.3.232 · Cited by 53
Strategies for Stemming the Tide of Antimicrobial Resistance
Low, D. E., & Scheld, W. M. (1998) · JAMA · doi:10.1001/jama.279.5.394 · Cited by 40
Ambulatory Care Visits for Treating Adverse Drug Effects in the United States, 1995–2001
Zhan, C., Arispe, I. E., Kelley, E., Ding, T., Burt, C. W., Shinogle, J. A., & Stryer, D. B. (2005) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(05)31050-6 · Cited by 39
Powers, J. H. (2007) · Clinical Infectious Diseases · doi:10.1086/519253 · Cited by 27
Frequency estimates from prescription drug datasets (revision of #04‐11‐066A)
Lin, S., Lambert, B. L., Tan, H., & Toh, S. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1149 · Cited by 6
Cited by
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Lin, D. M., Koskella, B., & Lin, H. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i3.162 · Cited by 1,135
Schuetz, P., Christ-Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Widmer, I., Neidert, S., Fricker, T., Blum, C., Schild, U., et al. (2009) · JAMA · doi:10.1001/jama.2009.1297 · Cited by 959
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Non-prescription antimicrobial use worldwide: a systematic review
Morgan, D. J., Okeke, I. N., Laxminarayan, R., Perencevich, E. N., & Weisenberg, S. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70054-8 · Cited by 947
International Consensus Statement on Allergy and Rhinology: Rhinosinusitis
Orlandi, R. R., Kingdom, T. T., Hwang, P. H., Smith, T. L., Alt, J. A., Baroody, F. M., Batra, P. S., Bernal‐Sprekelsen, M., Bhattacharyya, N., Chandra, R. K., et al. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21695 · Cited by 892
Metadata
- Authors
- Shehab, N., Patel, P. R., Srinivasan, A., & Budnitz, D. S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-09-15
- Volume
- 47
- Issue
- 6
- Pages
- 735-743
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2119080477
- Cited by
- 535
- References
- 34
- FWCI
- 31.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.